SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : World Heart Corp - WHRT and TSE/WHT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Hamilton who wrote (460)3/21/2001 2:48:59 PM
From: Dan Hamilton  Read Replies (1) of 500
 
Gettin' lonely on this 'ole thread by myself...

World Heart Corporation to Present to The New York Society of Security
Analysts 5th Annual Health Care Conference

OTTAWA, ON, Mar 21, 2001 /PRNewswire via COMTEX/ -- World Heart Corporation
(NASDAQ: WHRT, TSE: WHT) will present to the New York Society of Security
Analysts 5th Annual Health Care Conference on Tuesday, March 27, 2001 commencing
at 10:35 am, at the World Trade Center, Suite 4447, New York, NY.

Roderick M. Bryden, President and Chief Executive Officer, will provide an
update on the Company's products and pre-clinical trial progress.

The presentation will be audio cast live and available for replay for thirty
days at www.worldheart.com (under What's New and Financial Highlights).

World Heart Corporation is a global medical device company currently focused on
the development and commercialization of pulsatile ventricular assist devices.
Its Novacor(R) Left Ventricular Assist System is already well established in the
marketplace and its next generation technology, HeartSaverVAD(TM), is being
developed as a fully implantable assist device for patients with end-stage heart
disease. World Heart Corporation has offices in Canada and the United States.

Since 1937, the New York Society of Security Analysts has been the premier forum
in the United States for the exchange of investment information between senior
corporate officials and financial analysts, portfolio managers and others
involved in the investment decision making process.

Additional details on the Conference and the NYSSA are available on their
website at www.nyssa.org

Members of the media are asked to pre-register. Please contact:
Alyssa Shane, Registration Coordinator,
NYSSA, (212) 912-9249 ext.27; e-mail alyssa@nyssa.org.

SOURCE World Heart Corporation
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext